FR2550945B1 - Compositions d'endotoxines purifiees et leur application pharmacologique - Google Patents

Compositions d'endotoxines purifiees et leur application pharmacologique

Info

Publication number
FR2550945B1
FR2550945B1 FR8413133A FR8413133A FR2550945B1 FR 2550945 B1 FR2550945 B1 FR 2550945B1 FR 8413133 A FR8413133 A FR 8413133A FR 8413133 A FR8413133 A FR 8413133A FR 2550945 B1 FR2550945 B1 FR 2550945B1
Authority
FR
France
Prior art keywords
pharmacological application
purified endotoxin
endotoxin compositions
compositions
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8413133A
Other languages
English (en)
Other versions
FR2550945A1 (fr
Inventor
Edgar Ernst Ribi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of FR2550945A1 publication Critical patent/FR2550945A1/fr
Application granted granted Critical
Publication of FR2550945B1 publication Critical patent/FR2550945B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8413133A 1983-08-26 1984-08-23 Compositions d'endotoxines purifiees et leur application pharmacologique Expired FR2550945B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52696783A 1983-08-26 1983-08-26

Publications (2)

Publication Number Publication Date
FR2550945A1 FR2550945A1 (fr) 1985-03-01
FR2550945B1 true FR2550945B1 (fr) 1988-09-16

Family

ID=24099553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8413133A Expired FR2550945B1 (fr) 1983-08-26 1984-08-23 Compositions d'endotoxines purifiees et leur application pharmacologique

Country Status (22)

Country Link
JP (1) JPS6072825A (fr)
KR (1) KR880002223B1 (fr)
AT (1) AT389228B (fr)
AU (1) AU554039B2 (fr)
BE (1) BE900377A (fr)
CA (1) CA1225592A (fr)
CH (1) CH660125A5 (fr)
DE (2) DE3448164C2 (fr)
DK (1) DK389384A (fr)
ES (1) ES8606883A1 (fr)
FI (1) FI843204A (fr)
FR (1) FR2550945B1 (fr)
GB (1) GB2147806B (fr)
HU (1) HU191713B (fr)
IL (1) IL72675A (fr)
IN (1) IN157910B (fr)
IT (1) IT1177974B (fr)
NL (1) NL192326C (fr)
NO (1) NO843243L (fr)
NZ (1) NZ209233A (fr)
SE (1) SE8404090L (fr)
ZA (1) ZA846309B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2596990A1 (fr) * 1986-04-15 1987-10-16 Ribi Immunochem Research Inc Adjuvant immunologique a base d'emulsion de lipide et d'un adjuvant bacterien

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
DE10115310A1 (de) * 2001-03-28 2002-10-10 Nodar A Daniela Bakteriophagen-Präparation
KR100868443B1 (ko) * 2002-05-27 2008-11-11 주식회사 포스코 폭과 길이가 가변 조정되는 런치박스 제작장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (fr) * 1971-11-19 1975-02-07 Anvar
BE793260A (fr) * 1971-12-24 1973-06-22 Pasteur Institut Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant
NL7507376A (nl) * 1974-06-20 1975-12-23 Anvar Werkwijze voor de bereiding van bacteriele prepa- raten met anti-tumor, antivirale en adjuvans-acti- viteiten.
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2596990A1 (fr) * 1986-04-15 1987-10-16 Ribi Immunochem Research Inc Adjuvant immunologique a base d'emulsion de lipide et d'un adjuvant bacterien
FR2598622A1 (fr) * 1986-04-15 1987-11-20 Ribi Immunochem Research Inc Adjuvants immunologiques pour vaccins polysaccharidiques

Also Published As

Publication number Publication date
IT8448757A1 (it) 1986-02-24
FI843204A0 (fi) 1984-08-14
GB8420612D0 (en) 1984-09-19
SE8404090L (sv) 1985-02-27
GB2147806B (en) 1986-10-22
HU191713B (en) 1987-03-30
IN157910B (fr) 1986-07-19
AT389228B (de) 1989-11-10
NL192326B (nl) 1997-02-03
DE3431058A1 (de) 1985-03-07
DE3431058C2 (fr) 1987-06-11
FI843204A (fi) 1985-02-27
IL72675A (en) 1988-04-29
IT1177974B (it) 1987-09-03
NO843243L (no) 1985-02-27
DK389384A (da) 1985-02-27
IT8448757A0 (it) 1984-08-24
BE900377A (fr) 1985-02-18
KR880002223B1 (ko) 1988-10-20
ZA846309B (en) 1985-03-27
ATA273384A (de) 1989-04-15
ES8606883A1 (es) 1986-05-01
JPS6072825A (ja) 1985-04-24
AU554039B2 (en) 1986-08-07
DK389384D0 (da) 1984-08-13
NL8402515A (nl) 1985-03-18
ES535124A0 (es) 1986-05-01
KR850001696A (ko) 1985-04-01
CA1225592A (fr) 1987-08-18
JPH0556326B2 (fr) 1993-08-19
SE8404090D0 (sv) 1984-08-14
GB2147806A (en) 1985-05-22
DE3448164C2 (fr) 1987-06-25
NZ209233A (en) 1987-11-27
NL192326C (nl) 1997-06-04
HUT34887A (en) 1985-05-28
CH660125A5 (de) 1987-03-31
IL72675A0 (en) 1984-11-30
AU3221584A (en) 1985-02-28
FR2550945A1 (fr) 1985-03-01

Similar Documents

Publication Publication Date Title
GB2149301B (en) Pyridine-soluble extract - refined detoxified endotoxin composition and use
Blomgren Hematogenous infection of total joint replacement: an experimental study in the rabbit
ZA867347B (en) Medicaments to combat chronic graft-versus-host diseases and to combat autoimmune diseases,in particular systemic lupus erythematosus
IT8321287A0 (it) Procedimento per l'ottenimento della endotossina, disintossicata, raffinata, la endotossina ottenuta e l'impiego terapeutico di essa.
IT8722290A0 (it) Dispositivo integrato per schermare l'iniezione di cariche nel substrato.
IT8519402A0 (it) Dispositivo per produrre parti imbutite di materia artificiale termoplastica nonche' procedimento attuato con detto dispositivo
FR2604180B1 (fr) Composition d'organopolysiloxane
FR2550945B1 (fr) Compositions d'endotoxines purifiees et leur application pharmacologique
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
NO169838C (no) Fremgangsmaate for fremstilling av sulfaterte alkanol- eller alkylfenol-oksetylater med redusert innhold av 1,4-dioksan
ZA855462B (en) D'aminomethylene-2 indanediones-1,3 and its substitutes and their application to therapy
IT1170227B (it) Caviglia per l'assemblaggio di parti di mobili
IT9002117A0 (it) Procedimento per l'applicazione dello sperone e calzature costruite secondo il procedimento.
ES263793Y (es) "almohadon terapeutico".
ES265781Y (es) "dispositivo para composicion de muebles y estanterias".
IT1119156B (it) Procedimento per la preparazione di 2 alcossi 4 6 dicloro s triazine
LV5186A3 (lv) Kompozicija govju laktacijas stimulesanai un baribas izmantosanas pakapes paaugstinasanai
SE8702896D0 (sv) "seng-sufflett"
IT1228963B (it) Tavolo ad elevata flessibilita' di composizione.
BE879785R (fr) Nouveaux derives de l'hydroxy-4 thiazolidinethione-2, leur preparation et les compositions qui les contiennent
IT8721591A0 (it) Protesi per il pene in particolareper incrementare il diametro del pene.